Drug of abuse testing market to hit $9.97 billion by 2030

The drug of abuse testing market is projected to rise from $7.16 billion in 2025 to $7.64 billion in 2026, as workplace screening, forensic testing and substance-use monitoring expand. The Business Research Company expects the market to reach $9.97 billion by 2030, with North America leading and Asia-Pacific growing fastest.

Why it matters: - Drug of abuse testing is becoming more central to workplace compliance, emergency care, forensic investigations and treatment monitoring. - The market’s growth reflects broader pressure to detect substance misuse earlier and more often. - Rising testing demand also tracks with growing substance abuse rates worldwide.

What happened: - The Business Research Company said the global drug of abuse testing market will grow from $7.16 billion in 2025 to $7.64 billion in 2026. - The forecast implies a 6.7% compound annual growth rate in 2026. - The market is projected to reach $9.97 billion by 2030, at a 6.9% CAGR. - The company published a market report and offered a free sample and the full report.

The details: - Drug of abuse testing analyzes biological samples to detect and quantify illicit, controlled or harmful drugs. - The market’s recent growth has been supported by manual laboratory confirmation methods, workplace screening rules, forensic toxicology labs, immunoassay testing and opioid awareness campaigns. - Growth through 2030 is expected to come from more substance-abuse monitoring, broader mandatory workplace testing, rapid point-of-care kits, forensic and criminal investigations, and rehabilitation and treatment programs. - Reported trend lines include rapid onsite drug screening, tighter workplace compliance, more specialized forensic toxicology labs, anti-doping programs in sports and toxicology screening in emergency departments. - North America held the largest market share in 2025. - Asia-Pacific is expected to grow fastest during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, and the Middle East and Africa. - The new 2026 report package adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - The market outlook points to testing moving from a specialized lab function toward faster, more routine screening in workplaces and care settings. - The strongest growth regions suggest both mature regulatory markets and faster-expanding healthcare systems will keep driving demand. - The cited addiction figures underscore how public health need is feeding commercial testing demand.

What's next: - Expanded workplace testing rules and more rapid screening tools are likely to keep shaping buying decisions. - Testing vendors may focus on point-of-care systems, emergency-department protocols and forensic lab capabilities. - Market growth will likely continue to follow substance-use trends, regulatory pressure and healthcare investment.